MedPath

Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test

Not Applicable
Completed
Conditions
Anal Canal HPV Infection Diagnosis
Anal Dysplasia Diagnosis
Anal Cancer
Interventions
Device: HC2 collection kit with a swab or brush
Registration Number
NCT01104181
Lead Sponsor
Laser Surgery Care
Brief Summary

This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV and whether this aids in identifying individuals are risk for anal cancer or precancerous lesions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. male or female 18 years of age or older
  2. screened for anal dysplasia, including MSM and women -
Exclusion Criteria
  1. subject has had a previous treatment for anal cancer.
  2. subjects that have used enemas or other foreign substances, in the anal canal or anal sex within 24 hours of collection.
  3. subjects that have bleeding disorders or use anticoagulation treatments. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
swab and brush or swab and swabHC2 collection kit with a swab or brushwe will determine which collection method is superior
Primary Outcome Measures
NameTimeMethod
HC2 can accurately test for oncogenic HPV in anal specimensin approximately 12 months

Determination that HC2 testing in the anal canal can be performed

Secondary Outcome Measures
NameTimeMethod
Sensitivity and specificity of cytology with HC2in approximately 12 months

To determine if HC2 improves the sensitivity and specificity of anal cytology

Trial Locations

Locations (1)

Laser Surgery Care, Inc.

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath